ID   LB 84-3
AC   CVCL_W400
SY   LB84.3; LB-843; LB843
DR   Wikidata; Q54902011
RX   PubMed=2537114;
RX   PubMed=2783661;
RX   PubMed=10936422;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
RX   PubMed=2537114; DOI=10.1182/blood.V73.2.566.566;
RA   Duperray C., Klein B., Durie B.G.M., Zhang X., Jourdan M.,
RA   Poncelet P., Favier F., Vincent C., Brochier J., Lenoir G.M.,
RA   Bataille R.;
RT   "Phenotypic analysis of human myeloma cell lines.";
RL   Blood 73:566-572(1989).
//
RX   PubMed=2783661; DOI=10.1002/1097-0142(19890301)63:5<877::AID-CNCR2820630514>3.0.CO;2-6;
RA   Bataille R., Klein B., Jourdan M., Rossi J.-F., Durie B.G.M.;
RT   "Spontaneous secretion of tumor necrosis factor-beta by human myeloma
RT   cell lines.";
RL   Cancer 63:877-880(1989).
//
RX   PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2;
RA   Drexler H.G., Matsuo Y.;
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   multiple myeloma and plasma cell leukemia.";
RL   Leuk. Res. 24:681-703(2000).
//